Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Clin Pharmacol Ther. 2012 Dec;92(6):707-15. doi: 10.1038/clpt.2012.149. Epub 2012 Oct 10.
Type 2 diabetes (T2D) and obesity are complex disorders that constitute major public health problems. The evidence for familial aggregation of both T2D and obesity is substantial. To date, more than 150 genetic loci are associated with the development of monogenic, syndromic, or multifactorial forms of T2D or obesity. However, the proportion of overall trait variance explained by these associated loci is modest (~5-10% for T2D, ~2% for body mass index (BMI)). Some of the familial aggregation not attributable to known genetic variation, as well as many of the effects of environmental exposures, may reflect epigenetic processes. In this review, we discuss the evidence concerning the genetic contribution to individual risk of T2D and obesity, and explore the potential role of epigenetic mechanisms. We also explain how genetics, epigenetics, and environment are likely to interact to define the individual risk of disease.
2 型糖尿病(T2D)和肥胖症是复杂的疾病,构成了主要的公共卫生问题。T2D 和肥胖症的家族聚集证据是充分的。迄今为止,已有超过 150 个遗传位点与单基因、综合征或多因素形式的 T2D 或肥胖症的发生相关。然而,这些相关位点解释的总体性状变异比例是适度的(T2D 约为 5-10%,体重指数(BMI)约为 2%)。一些不能归因于已知遗传变异的家族聚集,以及许多环境暴露的影响,可能反映了表观遗传过程。在这篇综述中,我们讨论了遗传因素对 T2D 和肥胖症个体风险的贡献的证据,并探讨了表观遗传机制的潜在作用。我们还解释了遗传、表观遗传和环境如何相互作用来定义疾病的个体风险。